ABBOTT LABORATORIES — Director's Dealing 2004

Sep 2, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-09-01

Reporting Person: LIEPMANN HOLGER A (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2004-09-01	Common shares without par value	M	21280	$33.2314	Acquired	87715	Direct
2004-09-01	Common shares without par value	F	18666	$41.69	Disposed	69049	Direct
2004-09-01	Common shares without par value	S	3509	$42.00	Disposed	65540	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-09-01	Option (right to buy)	$33.2314	M	21280	Disposed	2013-02-13	Common shares (21280)	Direct
2004-09-01	Option (right to buy)	$41.69	A	18666	Acquired	2013-02-13	Common shares (18666)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	12795	Indirect
Common shares without par value	295	Indirect
Common shares without par value	296	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of August 31, 2004.

F2: Reporting person disclaims beneficial ownership of shares held by his daughters.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.